Skip to main content
. 2022 Oct 5;61(24):3651–3658. doi: 10.2169/internalmedicine.0190-22

Table 1.

Baseline Features of Patients with COVID-19 Requiring Supplemental Oxygen during Hospitalization.

Parameters Total (n=210) Non-ICU (n=144) ICU (n=66) p value
Age, years 70 (60-78) 69 (59-78) 72.5 (62-78) 0.35
Men, n 15 (69.0) 94 (65.3) 51 (77.3) 0.11
Body mass index, kg/m 2 25.4 (22.2-27.8) 24.8 (22.0-28.0) 25.6 (23.0-26.8) 0.97
Smoking, pack-year 8 (0-40) 3 (0-34) 15 (0-41) 0.09
Days from symptom onset to admission, days 6 (4-8) 7 (4-9) 6 (3-8) 0.02
Comorbidities
Hypertension, n 112 (53.3) 79 (54.9) 33 (50.0) 0.55
Diabetes, n 66 (31.4) 43 (7.1) 23 (34.8) 0.52
Cardiovascular disease, n 45 (21.4) 33 (22.9) 12 (18.2) 0.48
Cerebrovascular disease, n 24 (11.4) 14 (9.7) 10 (15.2) 0.25
Chronic kidney disease, n 8 (3.8) 4 (2.8) 4 (6.1) 0.26
Chronic obstructive pulmonary disease, n 43 (20.0) 25 (17.4) 18 (27.3) 0.14
Interstitial lung disease, n 17 (8.1) 7 (4.9) 10 (15.2) 0.03
Malignancy, n 7 (3.3) 4 (2.8) 3 (4.5) 0.68
Laboratory data
White blood cells, ×109/L 5.9 (4.5-7.3) 5.9 (4.5-7.4) 5.8 (4.4-7.0) 0.79
Lymphocytes, ×109/L 1.0 (0.7-1.2) 1.0 (0.7-1.2) 0.9 (0.7-1.2) 0.51
Platelets, ×109/L 185 (155-224) 187 (161-231) 176 (138-209) 0.02
Aspartate aminotransferase, IU/L 43 (29-57) 42 (30-56) 44.5 (28.0-62.5) 0.31
Alanine aminotransferase, IU/L 31 (20-48) 31 (19-48) 29 (20.0-49.3) 0.84
Lactate dehydrogenase, IU/L 302 (227-389) 295 (226-379) 310 (242-451) 0.17
Creatine, mg/dL 0.88 (0.71-1.04) 0.87 (0.71-1.05) 0.88 (0.72-1.01) 0.97
C-reactive protein, mg/dL 6.4 (3.3-11.8) 6.3 (3.3-11.3) 7.5 (2.7-13.5) 0.35
D-dimer, μg/mL 1.2 (0.9-1.7) 1.2 (0.9-1.7) 1.2 (0.8-1.7) 0.80
KL-6, U/mL 316 (232-496) 315 (229-488) 318 (246-602) 0.52
Ferritin, ng/mL 606 (336-1,131) 590 (289-1,204) 650 (463-1,097) 0.38

Categorical data are presented as numbers (percentages), and continuous data as medians (interquartile range). COVID-19: coronavirus disease 2019, ICU: intensive care unit, KL-6: Krebs von den Lungen 6